Benign Conditions

Benign Prostatic Hyperplasia

Bladder Cancer

Female Urology

Genitourinary Cancers

Genomic Testing

Hormone Therapy

Kidney Cancer

Challenging Anatomy

Innovative Techniques

Laser Lithotripsy

PCNL Tech & Devices

Ureteroscopy Tech & Devices

Kidney Stones

Men's Health

Next-Generation Imaging

Voiding Dysfunction

OAB and Incontinence

Pediatrics

Controveries in Urologic Cancer

Drug Therapy

Prostate Cancer

Sexual Dysfunction

UTUC

Cosmetic Surgery

Urologic Surgery

Business

Practice Management

Malpractice Consult

Health Law & Policy

Media

Case-Based Peer Perspectives

Investigator Perspectives 

Medical World News

Podcasts

Urology Medical Perspectives

UTv Videos

Peer Exchange

Special Report

Virtual Tumor Board

Insights

Medcast

Peers & Perspectives

Conferences

Conference Listing

Conference Previews 

Conference Recaps

Publications

Urology Times Journal

Editorial Advisory Board

Urologists in Cancer Care

Supplements and Featured Publications

Clinical Forums Recaps

CME/CE

Resources

Begin Your Journey: Tackling Burnout

Live Events

Interactive Tools

Job Board

Partners

Treatment Landscape Evolutions

Subscribe

Articles

Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.

The unfortunate news of President Biden’s diagnosis has put a spotlight on prostate cancer, offering an opportunity to educate on the risks of the disease and the benefits of screening.

Biden’s prostate cancer diagnosis underscores importance of screening, awareness

The test utilizes chromosomal instability signatures to predict resistance to taxane-based chemotherapy in metastatic prostate cancer.

Genomic test can predict resistance to chemotherapy in prostate cancer

The results demonstrated a favorable ratio between radiation doses absorbed in the tumor vs the doses delivered to key healthy organs. 

177Lu-rhPSMA-10.1 injection shows positive radiation dosimetry results in mCRPC

Oral sulopenem was approved by the FDA in October 2024 for the management of uUTIs. 

Phase 3 data of oral sulopenem for uUTIs published in NEJM Evidence

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

About Us

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do not sell my Personnal Information

Urology Times – News & Insights for Urologists & Health Professionals

Facebook

LinkedIn

Spotlight

Peers and Perspectives

Clinical

1rem

In this series, experts discuss best practices for clinical use of onabotulinumtoxinA in the managements of overactive bladder. 

Clinical Use of OnabotulinumtoxinA for Overactive Bladder

This series showcases an ongoing clinical trial of detalimogene voraplasmid and highlights the evolving treatment landscape of non–muscle invasive bladder cancer.

Emerging Clinical Trials within NMIBC

Neal Shore, MD, FACS and Rana McKay, MD discuss recent advances in understanding and targeting androgen receptor signaling in metastatic prostate cancer and emerging treatment approaches.

Advancements in Targeting the Androgen Receptor Pathway in Metastatic Prostate Cancer

This digital series features articles and videos with insights and expert viewpoints on PSMA-PET and the evolving imaging paradigm that is revolutionizing the diagnosis and treatment of patients with prostate cancer.

PSMA-PET and the Evolving Imaging Paradigm in Prostate Cancer

This digital series comprised of videos and articles led by experts in the field examines the evolving role of novel imaging modalities in the identification and management of patients with prostate cancer.

The Evolving Paradigm of Prostate Cancer Imaging and New Modalities 

This digital series explores the challenges and unmet needs in the management of advanced/metastatic prostate cancer with focus on the use of leuprolide, and the clinical and financial factors physicians consider when recommending leuprolide as a treatment option.

Overview of Advanced/Metastatic Prostate Cancer

This series comprised of videos and articles features experts on prostate cancer sharing clinical insights on the role of micronized abiraterone.

Clinical Use of Micronized Abiraterone for Patients with Prostate Cancer

This series comprised of videos and articles explores the role of perirectal spacers and the multidisciplinary approach to treating patients with prostate cancer.

The Role of Perirectal Spacers in the Treatment of Prostate Cancer

This digital series examines challenges and unmet needs in the management of advanced/metastatic prostate cancer with emphasis on leuprolide treatment and understanding the interplay among clinical, economic, and organizational management perspectives that physicians consider when prescribing leuprolide.

Expert Perspectives on Advanced/Metastatic Prostate Cancer

This digital series explores challenges and unmet needs in the treatment of low-grade upper tract urothelial carcinoma (LG-UTUC) and reviews key advancements in the therapeutic landscape with emphasis on emerging precision medicine-based approaches.

The Evolving Treatment Landscape of Low-grade Upper Tract Urothelial Carcinoma